ProLynx announces SBIR grant award to develop novel technology for dual receptor agonists

ProLynx announces SBIR grant award to develop novel technology for dual receptor agonists | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado

The only conference focused solely on the pharmaceutical development of peptide therapeutics.

ProLynx announces SBIR grant award to develop novel technology for dual receptor agonists

Peptide News from Biotech and Pharma, Raw News September 25, 2017

... with a combination of our long-acting GLP-1 receptor agonist plus a glucagon or GIP (glucose-dependent insulinotropic peptide) receptor agonist.